Risankizumab and guselkumab for psoriasis: a 1-year real-world practice indirect comparison
Abstract Background: Psoriasis is a chronic inflammatory skin disease with a genetic predisposition and autoimmune component, often treated with immunomodulators such as biologic therapies. Objectives: In this study, the authors evaluated the effectiveness and safety of two of these over a 52-week...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Sociedade Brasileira de Dermatologia
2025-04-01
|
| Serie: | Anais Brasileiros de Dermatologia |
| Soggetti: | |
| Accesso online: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962025000200305&lng=en&tlng=en |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|